Jun 1, 2026 – 2.37pmKURK Biosciences, a natural health supplement company backed by British actor Tom Hardy and former Macquarie Group executive Bill Moss, is seeking to raise capital before the end of 2026.The London-based company, co-founded by Wollongong native Trent Scanlen, has begun discussions for a funding round at a pre-money valuation of at least £20 million ($37 million), Street Talk understands.Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones.Kanika Sood is a journalist based in Sydney who writes for the Street Talk column.Emma Rapaport is a co-editor of the Street Talk column. Prior to that, she was a markets reporter at The Australian Financial Review.Subscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber?
Tom Hardy-backed turmeric supplement provider weighs capital raising
The London-based company, co-founded by a Wollongong native, has begun discussions for a funding round at a pre-money valuation of at least $37 million.
156 words~1 min read
